AGT and Alzheimer disease: Immunohistochemistry (IHC) experiments demonstrated that losartan or resveratrol treatment influenced the expression of phosphorylated TauT231 in hippocampal areas CA1, CA3, and DG in rats with Ang-II-induced AD (Figure 3A,B).